| Literature DB >> 35652533 |
Carolyn Ee1, Anna C Singleton2, Michael de Manincor1, Elisabeth Elder3, Nikki Davis4, Christine Mitchell5, Tinashe Dune1, Freya MacMillan1, Kate McBride1, Suzanne Grant1.
Abstract
INTRODUCTION: Weight gain is common after breast cancer. Yoga, mindfulness meditation, and acupuncture may assist with managing weight. However, evidence on effectiveness is limited. This study assessed the feasibility and acceptability of recruiting for and implementing a randomized controlled trial (RCT) evaluating these interventions as adjuncts to lifestyle interventions (diet and exercise) for weight management in women with breast cancer.Entities:
Keywords: acupuncture; breast neoplasms; complementary therapies; mindfulness; qualitative research; weight gain; yoga
Mesh:
Year: 2022 PMID: 35652533 PMCID: PMC9168877 DOI: 10.1177/15347354221099540
Source DB: PubMed Journal: Integr Cancer Ther ISSN: 1534-7354 Impact factor: 3.077
Participant Characteristics Including Demographics, Medical History, and Complementary Medicine/Therapy Use.
| Demographic characteristics | n/N (%) |
|---|---|
| Current age, mean years (standard deviation) | 53.8 (12.3) |
| Ethnicity | |
| European/Caucasian/Anglo Saxon | 28 (75.7) |
| Asian or Oceanic (including New Zealand first peoples, Polynesian, Micronesian) | 9 (24.3) |
| Education | |
| University degree or above | 26 (70.2) |
| High school/vocational college | 11 (29.8) |
| Employment | |
| Employee | 22 (59.5) |
| Retired or volunteer work | 6 (16.2) |
| Self-employed | 5 (13.5) |
| Unable to work due to illness or other reasons | 4 (10.8) |
| Relationship status | |
| Married/de facto | 26 (70.3) |
| Single | 6 (16.2) |
| Divorced/separated/widowed | 5 (13.5) |
| Number of children | |
| None | 11 (29.7) |
| 1 | 6 (16.2) |
| 2 | 13 (35.1) |
| >3 | 7 (18.9) |
| Medical history | |
| Diagnosis | |
| Localized | 28 (75.7) |
| DCIS/LCIS | 6 (16.2) |
| Metastatic or inflammatory | 3 (8.1) |
| Years since diagnosis, mean (SD), range | 5.6 (5.3), 0-20 |
| Postmenopausal at diagnosis | 13 (35.1) |
| Treatment | |
| Sentinel node biopsy/axillary clearance | 31 (83.8) |
| Radiotherapy | 26 (70.3) |
| Lumpectomy | 23 (62.2) |
| Mastectomy | 18 (48.6) |
| Selective estrogen receptor modulator (eg, Tamoxifen) | 18 (48.6) |
| Aromatase inhibitor (eg, Anastrozole) | 18 (48.6) |
| Adjuvant chemotherapy | 15 (40.5) |
| Neoadjuvant chemotherapy | 12 (32.4) |
| GNRH agonist (Goserelin/Zoladex) | 8 (21.6) |
| Targeted therapy (eg, Herceptin) | 4 (10.8) |
| CDK inhibitor (Abemaciclib—clinical trial) | 1 (2.7) |
| Current weight (kg), mean (SD), range | 73.1 (14.5), 40-108 |
| Current BMI (kg/m2), mean (SD), range | 27.3 (4.7), 17.5-37.4 |
| Weight at diagnosis (kg) (n = 35), mean (SD), range | 71.9 (16.4), 40-121 |
| BMI at diagnosis (kg/m2) (n = 35), mean (SD), range | 26.8 (5.7), 17.3-42.2 |
| Weight change since diagnosis (kg) (n = 35), mean (SD), range | 1.1 (9.6), −21 kg to +26 kg |
| Weight pattern since diagnosis | |
| Gained weight overall | 14 (37.8) |
| Fluctuated a great deal | 10 (27.0) |
| Lost weight | 7 (18.9) |
| Stable | 6 (16.2) |
| Complementary medicine or therapy use | |
| Any complementary medicine or therapy use for any reason in past 12 months | 23 (62.2) |
| Supplements | 14 (37.8) |
| Massage | 11 (29.7) |
| Relaxation techniques | 9 (24.3) |
| Yoga | 8 (21.6) |
| Essential oils | 6 (16.2) |
| Meditation | 6 (16.2) |
| Acupuncture | 5 (13.5) |
| Chiropractic | 4 (10.8) |
| Naturopathy | 2 (5.4) |
| Osteopathy | 2 (5.4) |
| Reflexology | 2 (5.4) |
| Prayer | 2 (5.4) |
| Kinesiology | 2 (5.4) |
| Chinese herbal medicine | 1 (2.7) |
| Bowen therapy | 1 (2.7) |
| Yoga delivery (n = 8) | |
| Group class in yoga studio | 4 (50.0) |
| Self-practice, general | 4 (50.0) |
| Online, pre-recorded | 3 (37.5) |
| Online, live | 3 (37.5) |
| Group class in a non-yoga studio (eg, gym) | 2 (25.0) |
| One-on-one in person | 1 (12.5) |
| Self-practice designed by a teacher | 1 (12.5) |
| Yoga therapy | 0 (0.0) |
Abbreviations: DCIS, ductal carcinoma in-situ; LCIS, lobular carcinoma in-situ.